Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

LCRS Endo > T1DM > Flashcards

T1DM Flashcards

1
Q

main characteristic of T1DM?

difference to T2DM?

A

complete lack of insulin

whilst T2DM is the relative lack of insulin and insensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how can T1DM unusually end up presenting in later life?

A

as Latent Autoimmune Diabetes in Adults (LADA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

is DKA a feature of T1DM?

A

yes

it is not a significant feature of T2DM as there is enough insulin present to suppress ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How can monogenic diabetes present itself?

A

Type 1 or Type 2

e.g. MODY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what can also cause a diabetes presentation?

A

pancreatic damage e.g. due to alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which type has more of a genetic role in its development?

A

T2DM

T1 is usually autoimmune

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why is beta cell failure in T2 relative?

A

insulin is produced by not enough to stimulate the insulin receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what mediates autoimmune destruction of beta cells?

A

multiple relapse-remitting processes include different antibodies destroying the cells in phases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the honeymoon phase in autoimmune destruction of beta cells

A

last phase where beta cells are in non-hyperglycaemia response with just enough insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what happens to cause a breach in autoimmunity control?

A

Tregs normally keep check on effector T cells that are destructive
the Tregs are eventually overcome and complete destruction of beta cells takes place

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what increases the risk of autoimmune diabetes

A

a background of autoimmune disorders increases the prevalence of other autoimmune disorders
a risk in relatives

test for auto-antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which alleles pose a significantly increased risk of T1?

A

HLA-DR alleles specifically DR3 and DR4 have significant risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

possible environmental triggers of T1?

A

autumn/winter months see more T1DM diagnoses due to possible infection cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the markers of T1DM?

A

o Islet cell antibodies.
o Insulin antibodies.
o Glutamic acid decarboxylase (GADA- created GABA neurotransmitter)
o Insulinoma-associated-2 autoantibodies receptor like family.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the symptoms of T1DM?

A

 Polyuria
 nocturia.
 Polydipsia.

 Blurring of vision.
 Thrush- yeast infection
 Weight loss.
 Fatigue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the signs of T1DM?

A 
	Dehydration.
	Cachexia – muscle wasting/weakness.
	Hyperventilation – Kussmahl breathing 
	Ketone smell.
	Glycosuria and Ketonuria.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the function of insulin

A

release post-prandial to increase the absorption of glucose

- inhibits glycerol leaving adipocytes (therefore no gluconeogenesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the result of a lack of insulin on adipocytes?

A

FFAs are released and turned into ketone bodies inside the liver

these KBs are taken up by muscles and the brain

causes ketonuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are the aims of treatment for T1?

A
  • reduce early mortality
  • avoid acute metabolic decompensation
  • prevent long term complications (retinopathy, nephropathy, vasc disease)
20
Q

how is life preserved in T1?

A

using exogenous insulin

21
Q

what dietary changes need to be made?

A
  • reduce calories of fat and refined carbs
  • increase calories of complex carbs and increase soluble fibre
  • distribute food evenly throughout the day, regular meals and snacks
22
Q

what must be taken into consideration when giving insulin?

A

people have a basal level of insulin so treatment must retain this

23
Q

when must insulin be given?

A
  • meals: short acting insulin, human or analogue (lispro, Aspart, Glulisine)
  • background: long-acting, non-c bound to zinc/protamine or analogue (Glargine, Determir , Degludec)
24
Q

alternative treatment option

A
  • insulin pumps: gives continuous delivery, pre-programmed basal and bolus rates but does not measure glucose feedback
  • islet cells transplants: donor donates pancreas islet cells inserted into diabetic’s liver portal vessels to release insulin ; patient on immunosuppressants; treatment reserved for those with erratic control of diabetes
25
Q

how can treatment be monitored?

A
  • capillary monitoring: either via a continuous monitor attached to the belly or through finger pricks. Allows adjustment of insulin dose.
  • HbA1c red cells monitoring: glucose binds to RBCs irreversibly so can give a long-term view of glucose control. Can allow you to monitor blood glucose over a 3-month long period (life of a RBC).
26
Q

what is a low Hb1AC associated with?

A

Lowering HbA1C is associated with a lower risk of microvascular complications.

27
Q

acute complications of T1?

A
  • metabolic acidosis (ketoacidosis)

- hyperglycaemia

28
Q

what causes the acute complication: metabolic acidosis?

A

due to circulating acetoacetate/hydroxybutyrate (ketone bodies) and osmotic dehydration and poor tissue perfusion.

[Diabetic ketoacidosis CAN occur in T2DM and new onset diabetes BUT it is most common in T1DM]

29
Q

what essentially causes hyperglycaemia (high glucose in the blood)? pathophysiology

A
  • reduced uptake of glucose
  • reduced tissue glucose utilisation
  • increased HGO.
  • In treating hyperglycaemia, patients MAY become hypoglycaemic.
30
Q

what may be a consequence of treating diabetes?

A

hypoglycaemia (<3.6mmol/L)

  • most mental processes inhibited at <3
  • coma at <2 with long term effects on brain
  • severe hypoglycaemia contribute to arrhythmia and sudden death
  • recurrent hypos–> loss of warning to body
31
Q

who are affected by hypos?

A

o Low quality glycaemic control patients.

o More common in patients with low HbA1C.

32
Q

when can hypos strike?

A

o Anytime but often a clear pattern (i.e. pre-lunch hypos).

o Nocturnal which are common but not often recognised by the patient.

33
Q

what are the triggers of hypos?

A

o New exercise.
o Missed meals.
o Inadequate snacks and alcohol.
o Bad insulin regime.

34
Q

symptoms and signs of hypoglycaemia

A

<3.6 mmol/L

  • increased autonomic activation (palpitations, sweating, tremor)
  • impaired CNS functions
35
Q

increased autonomic activation due to hypoglycaemia

A 
o	Palpitations.
o	Tremor.
o	Sweating.
o	Pallor/cold extremities.
o	Anxiety.

hypoglycaemia increases the release of catecholamines in order to increase glucose production and decrease glucose utilisation in order for the brain to have sufficient glucose. There is increased adrenergic activity.

36
Q

what are the impaired CNS function symptoms due to hypoglycaemia?

A

o Drowsiness, confusion and altered behaviour.

o Coma.

37
Q

treatment of hypoglycaemia due to diabetes treatment

A
  • oral feed glucose (tablets or solution) and complex carbs
  • parenteral if unconscious
    (IV dextrose, 1mg glucagon IM)
38
Q

how is DKA precipitated?

A

o New diagnosis of T1DM.
o Not taking insulin.
o Intercurrent stress (e.g. pneumonia).
o Fasting and not taking enough insulin.

39
Q

what are the main 4 causes of DKA?

A
  • fasting
  • insulin def
  • stress hormones
  • dehydration
40
Q

how is metabolic acidosis caused?

A

due to ketones (these are slightly acidic)

  • produced as a result of fatty acid breakdown (lipolysis)
  • reduction in bicarbonate production decreases blood pH

leads to

  • Kussmahls respiration to blow off CO2
  • hyperventilation
  • vomiting
  • abdominal pain
  • fruity smell in breath
  • ketonuria
41
Q

urinary losses in DKA

A

water lost in urine so Na+ is lost

K+ is also lost but even though acidosis shows high K+to compensate for the acidosis, total body K+ is low

42
Q

clinical features of DKA

A

o Polyuria & polydipsia due to diuresis.
o Dehydration.

due to drop in blood pH:
o	Hyperventilation.
o	Abdominal pain and vomiting.
o	Coma.
o	Glycosuria and Ketonuria.
43
Q

investigations for DKA

A 
o	Capillary and plasma glucose.
o	Creatinine, K+, Na+.
o	FBC.
o	Arterial blood gas.
o	Amylase.
o	ECG, CXR, septic screen.
44
Q

what are the treatments for DKA?

[FIPBO]

A 
1) Fluids:
H2O as normal saline
2) Insulin:
dependent on blood glucose levels
In second phase DKA, give 5% dextrose. 
3) Potassium: 
usually found intracellular 
4) Bicarbonate (increase pH)
5) Other:
Cardiac monitor, catheterise, antibiotics, NG tube, heparin, arterial line or central line
45
Q

why does blood pH drop?

A

ketone bodies are slightly acidic

causes hyperventilation/Kussmahls in order to remove CO2

LCRS Endo (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions